1. Home
  2. HAO vs SNPX Comparison

HAO vs SNPX Comparison

Compare HAO & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAO
  • SNPX
  • Stock Information
  • Founded
  • HAO 2018
  • SNPX 2012
  • Country
  • HAO China
  • SNPX United States
  • Employees
  • HAO N/A
  • SNPX N/A
  • Industry
  • HAO
  • SNPX Medicinal Chemicals and Botanical Products
  • Sector
  • HAO
  • SNPX Health Care
  • Exchange
  • HAO NYSE
  • SNPX Nasdaq
  • Market Cap
  • HAO 3.3M
  • SNPX 3.1M
  • IPO Year
  • HAO 2024
  • SNPX N/A
  • Fundamental
  • Price
  • HAO $1.41
  • SNPX $2.33
  • Analyst Decision
  • HAO
  • SNPX Strong Buy
  • Analyst Count
  • HAO 0
  • SNPX 1
  • Target Price
  • HAO N/A
  • SNPX $14.00
  • AVG Volume (30 Days)
  • HAO 68.3K
  • SNPX 11.5K
  • Earning Date
  • HAO 05-31-2025
  • SNPX 05-14-2025
  • Dividend Yield
  • HAO N/A
  • SNPX N/A
  • EPS Growth
  • HAO 20.20
  • SNPX N/A
  • EPS
  • HAO 0.19
  • SNPX N/A
  • Revenue
  • HAO $48,970,924.00
  • SNPX N/A
  • Revenue This Year
  • HAO N/A
  • SNPX N/A
  • Revenue Next Year
  • HAO N/A
  • SNPX N/A
  • P/E Ratio
  • HAO $6.91
  • SNPX N/A
  • Revenue Growth
  • HAO 71.88
  • SNPX N/A
  • 52 Week Low
  • HAO $0.09
  • SNPX $1.84
  • 52 Week High
  • HAO $10.60
  • SNPX $5.38
  • Technical
  • Relative Strength Index (RSI)
  • HAO 53.02
  • SNPX 49.26
  • Support Level
  • HAO $1.08
  • SNPX $2.05
  • Resistance Level
  • HAO $1.40
  • SNPX $2.21
  • Average True Range (ATR)
  • HAO 0.17
  • SNPX 0.18
  • MACD
  • HAO 0.03
  • SNPX 0.04
  • Stochastic Oscillator
  • HAO 87.97
  • SNPX 79.51

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

Share on Social Networks: